Seek and you will find: Antibody and the liver

American Journal of Transplantation

Volumn 11, Issue 3, 2011, Pages 424-425

  Knechtle, Stuart J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RITUXIMAB;

ANTIBODY MEDIATED REJECTION; EDITORIAL; GRAFT RECIPIENT; GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVER; LIVER BIOPSY; LIVER INJURY; LIVER TRANSPLANTATION; PLASMAPHERESIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; SPLENECTOMY;

GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; ISOANTIBODIES; LIVER TRANSPLANTATION; TISSUE DONORS; TREATMENT OUTCOME;

EID: 79951969142     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03410.x     Document Type: Editorial

References (9)

1. Calne RY, Sells RA, Pena JR et al. Induction of immunological tolerance by porcine liver allografts. Nature 1969; 223: 472-476.
2. Neumann UP, Lang M, Moldenhauer A et al. Significance of a T-lymphocytotoxic crossmatch in liver and combined liver-kidney transplantation. Transplantation 2001; 71: 1163-1168. (Pubitemid 32448835)
3. Starzl TE, Demetris DE, Todo S et al. Evidence for hyperacute rejection of human liver grafts: The case of the canary kidneys. Clin Transplant 1989; 3: 37-45. (Pubitemid 19150716)
4. Furuya T, Murase N, Nakamura K et al. Preformed lymphocytotoxic antibodies: The effects of class, titer, and specificity on liver vs. heart allografts. Hepatology 1992; 16: 1415-1422.
5. Chretien P, Chousterman M, Alsamad A et al. Non-organ-specific autoantibodies in chronic hepatitis C patients: Association with histological activity and fibrosis. J. Autoimmun 2009; 32: 201-205.
6. Demetris AJ, Adeyi O, Bellamy CO, Clouston A, Charlotte F, Czaja A. Banff Working Group. Liver biopsy interpretation for causes of late liver allograft dysfunction Hepatology 2006; 44: 489-501.
7. Racusen LC, Solez K, Colvin RB et al. Antibody-mediated rejection criteria - An addition to the Banf '97 classification of renal allograft rejection. Am J Transplant 2003; 3: 708.
8. Musat AI, Agni RM, Wai PY et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am J Transplant 2010.
9. Bellamy COC, Herriot MM, Harrison DJ, Bathgate AJ C4d immunopositivity is uncommon in ABO-compatible liver allografts, but correlates partially with lymphocytotoxic antibody status. Histopathology 2007; 50: 739-749. (Pubitemid 46683930)